Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.36 |
| ▸ | NFE2L2 | Q16236 | 4/20 | 0.35 |
| ▸ | RXFP1 | Q9HBX9 | 4/20 | 0.33 |
| ▸ | COMT | P21964 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 3/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 2/20 | 0.31 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | EDNRA | P25101 | 1/20 | 0.31 |
| ▸ | SLC40A1 | Q9NP59 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17992185 | 0.86 | COMT (0.38) | COMTMEN1KMT2ASCN9AKDM4E | |
| SCHEMBL20626878 | 0.86 | AAK1 (0.34) | NFE2L2COMTMEN1KMT2AALDH1A1 | |
| SCHEMBL20626880 | 0.84 | PLCG1 (0.32) | COMT | |
| SCHEMBL17992235 | 0.79 | CYP4F2 (0.34) | NFE2L2COMT | |
| SCHEMBL19767080 | 0.77 | COMT (0.35) | SLC22A12COMTMEN1KMT2APOLB | |
| SCHEMBL22518699 | 0.77 | DGAT1 (0.35) | COMT | |
| SCHEMBL19767069 | 0.77 | AAK1 (0.35) | NFE2L2COMTMEN1KMT2AALDH1A1 | |
| SCHEMBL29672225 | 0.77 | DGAT1 (0.35) | COMT | |
| SCHEMBL19767079 | 0.77 | COMT (0.39) | COMTMEN1KMT2APOLBTSHR | |
| SCHEMBL18908804 | 0.77 | ALDH1A1 (0.32) | COMTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10173997-B2 | Bipyridine compound and use of same for noxious arthropod control | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-01-08 | — | — | US | disclosed |
| WO-2017073733-A1 | PEST CONTROL COMPOSITION AND USE THEREOF | 住友化学株式会社 | 2017-05-04 | — | — | WO | disclosed |
| WO-2016121969-A1 | BIPYRIDINE COMPOUND AND USE OF SAME FOR NOXIOUS ARTHROPOD CONTROL | 住友化学株式会社 | 2016-08-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10173997-B2 | Bipyridine compound and use of same for noxious arthropod control | BBOX1, ACHE, MORF4L1 | SLC22A12 4849/4885NFE2L2 294/4885RXFP1 3411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.